Gallbladder disease, including cholelithiasis, occurred at a higher rate in semaglutide-treated patients than placebo in STEP-1 (2.6% vs
Dehydration, which may occur due to vomiting or diarrhea
Other frequently reported side effects associated with semaglutide may include headache, abdominal pain, nasopharyngitis, dizziness, gastroenteritis, constipation, and GERD.[2] Semaglutide has a boxed warning, or a serious safety warning by the FDA, for the risk of thyroid C-cell tumors.[2] Additional safety warnings and precautions are acute pancreatitis, gall bladder disease, kidney injury, increased heart rate, and hypersensitivity reactions
Red Fox Peptides carries both Retatrutide and AOD-9604 with third-party testing and ships from British Columbia